Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum
Crossref DOI link: https://doi.org/10.1007/s00280-014-2640-4
Published Online: 2014-11-27
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Ji Hyun
Lee, Jae-Lyun
Text and Data Mining valid from 2014-11-27